Angeles Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Sell |
10,481
-3,263
| -24% | -$225K | 0.05% | 138 |
|
|
2025
Q1 | $954K | Sell |
13,744
-175
| -1% | -$12.2K | 0.08% | 96 |
|
|
2024
Q4 | $1.2M | Buy |
13,919
+225
| +2% | +$19.4K | 0.1% | 75 |
|
|
2024
Q3 | $1.63M | Sell |
13,694
-429
| -3% | -$51.1K | 0.14% | 58 |
|
|
2024
Q2 | $2.02M | Sell |
14,123
-44
| -0.3% | -$6.28K | 0.19% | 48 |
|
|
2024
Q1 | $1.82M | Buy |
14,167
+41
| +0.3% | +$5.26K | 0.18% | 47 |
|
|
2023
Q4 | $1.46M | Sell |
14,126
-89
| -0.6% | -$9.21K | 0.18% | 51 |
|
|
2023
Q3 | $1.29M | Sell |
14,215
-15,281
| -52% | -$1.39M | 0.18% | 47 |
|
|
2023
Q2 | $2.39M | Buy |
29,496
+534
| +2% | +$43.2K | 0.33% | 30 |
|
|
2023
Q1 | $2.3M | Buy |
28,962
+6,384
| +28% | +$508K | 0.34% | 33 |
|
|
2022
Q4 | $1.53M | Buy |
22,578
+13,752
| +156% | +$931K | 0.27% | 49 |
|
|
2022
Q3 | $440K | Buy |
+8,826
| New | +$440K | 0.09% | 99 |
|